RESULTS: In the validation set, TUMNet per-frame sensitivity was 88% (186/211) and per-tumor sensitivity was 90% (9/10) with a per-frame specificity of 99% (992/1002). TUMNet accurately detected all 16 tumors that were resected in the ongoing prospective test cohort (n[9; 15 cancer, 1 benign).
INTRODUCTION AND OBJECTIVES:
This study is designed to explore the relationship between standard PSMA uptake values (SUVs) with prostate cancer (PCa) aggressiveness and its role in evaluation of clinically significant PCa (csPCa) and risk stratification.
METHODS: e retrospectively enrolled 51 patients who underwent 68Ga-PSMA PET/CT (PET/CT) before radical prostatectomy (RP). PET/CT results were corrected with whole mount histology. CONCLUSIONS: PSMA uptake on PSMA PET/CT positively correlated with Gleason score, T stage, initial PSA and tumor volume. Both SUVmax and SUVmean can be applied as parameters for csPCa detection and risk classification. 
